Oculis Holding AG OCS
NASDAQ OCS
$12.17 +0.00 (+0.00%)
At close: Sep 4, 2026 · 4:00 PM EDT

Oculis Holding AG (OCS) Accounts Payables (2021 - 2026)

Oculis Holding AG (OCS) posted quarterly Accounts Payables of $5.7 million for Q1 2026, up 18.64% year-over-year from $4.8 million in Q1 2025, and up 154.94% quarter-over-quarter from $2.3 million in Q4 2025.

Analysis

Oculis Holding AG (OCS) Accounts Payables (2021 - 2026) Analysis & Trends

Oculis Holding AG's Accounts Payables history runs 6 years deep, the most recent figure standing at $5.7 million for Q1 2026.

  • In Q1 2026, Accounts Payables rose 18.64% year-over-year to $5.7 million; the TTM figure through Mar 2026 stood at $5.7 million (up 18.64% YoY), while the FY2025 annual figure was $2.2 million, down 67.47% from the prior year.
  • Accounts Payables for Q1 2026 stood at $5.7 million, up from $2.3 million in the prior quarter.
  • The five-year high for Accounts Payables was $8.6 million in Q4 2023, with the low at $1.3 million in Q1 2024.
  • The 5-year median for Accounts Payables is $4.4 million (2023), against an average of $4.4 million.
  • The sharpest annual moves came in 2022 and 2025: Accounts Payables surged 349.18% in 2022, then sank 72.97% in 2025.
  • Oculis Holding AG's Accounts Payables stood at $4.0 million in 2022, then jumped by 113.34% to $8.6 million in 2023, then dropped by 21.74% to $6.7 million in 2024, then tumbled by 66.4% to $2.3 million in 2025, then soared by 154.94% to $5.7 million in 2026.
  • Business Quant data shows OCS's Accounts Payables at $5.7 million in Q1 2026, $2.3 million in Q4 2025, and $1.5 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 429.50 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 1.16 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 1.52 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 167.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 88.42 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 470.30 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 108.02 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 35.57 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 428.93 Mn
10 Oculis Holding AG 634.75 Mn 345.87 Mn - 3.39 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.39 Mn
Mar 31, 2026 5.74 Mn
Dec 31, 2025 2.25 Mn
Sep 30, 2025 1.53 Mn
Jun 30, 2025 1.45 Mn
Mar 31, 2025 4.84 Mn
Dec 31, 2024 6.70 Mn
Sep 30, 2024 5.65 Mn
Jun 30, 2024 3.52 Mn
Mar 31, 2024 1.35 Mn
Dec 31, 2023 8.56 Mn
Sep 30, 2023 7.60 Mn
Jun 30, 2023 4.36 Mn
Dec 31, 2022 4.01 Mn
Dec 31, 2021 893,629.73